Skip to main content

Funded Grants

Filter by:
Clear Filters
Filter by:

706 results found

Biological and Pathological relevance of hnRNP A1B; An alternative splice variant of TDP-43

In 97 per cent of ALS cases and nearly half of cases of frontotemporal dementia, the TDP-43 protein is misplaced to an area outside the cell nucleus of the motor neuron called the cytoplasm.


Grant type
Capacity building grants
Area of Research
Neurodegeneration
Competition
ALS Canada - Brain Canada Trainee Program 2019
Province
Québec
Start Date
2019

Validation of small molecules preventing TDP-43 aggregation as a therapeutic for Amyotrophic Lateral Sclerosis

TDP-43 is a protein that behaves abnormally in the motor neurons of 97 per cent of people with ALS.


Grant type
Capacity building grants
Area of Research
Neurodegeneration
Competition
ALS Canada - Brain Canada Trainee Program 2019
Province
Ontario
Start Date
2019

2019 Turnbull-Tator Award in Spinal Cord Injury and Concussion Research


Grant type
Capacity building grants
Area of Research
Injury
Competition
Turnbull-Tator Award in Spinal Cord Injury and Concussion Research
Province
British Columbia
Start Date
2019

Exploitation of a new pharmacological target for the development and validation of new anti-inflammatory drugs

Neuroinflammation has been implicated in a diverse array of degenerative conditions, ranging from Multiple Sclerosis  to  Alzheimer’s  disease.


Grant type
Team grants
Area of Research
Neurodegeneration
Competition
CQDM - Brain Canada - SynergiQc
Province
Québec
Start Date
2019

Novel First-In-Class Melatonin MT2 Receptor Agonist for Neuropathic Pain: Investigational New Drug (IND) – Enabling Studies

Neuropathic pain is a chronic pain disorder resulting from damage to the nerves.


Grant type
Team grants
Area of Research
Central Nervous System
Competition
CQDM - Brain Canada - SynergiQc
Province
Québec
Start Date
2019

Systematic assessment of retinal output following optogenetic vision therapy

Optogenetic strategies – the ability to activate normally light-insensitive neurons with light – are being used in clinical trials to restore light sensitivity to the retina of vision impaired patients.


Grant type
Capacity building grants
Area of Research
Central Nervous System
Competition
Azrieli Foundation - Brain Canada Early-Career Capacity Building grants
Province
Québec
Start Date
2019

Neurodegenerative potential for microglia in a progressive MS model

Multiple Sclerosis (MS) is a disease where the immune system attacks the brain and spinal cord.


Grant type
Capacity building grants
Area of Research
Neurodegeneration
Competition
Azrieli Foundation - Brain Canada Early-Career Capacity Building grants
Province
Alberta
Start Date
2019

Electrically guided transcranial stimulation of cells chemogenically primed for excitability a novel, non-invasive and cell type-specific approach

Dr Bambico proposes to test a new and potentially groundbreaking experimental technique called EC stimulation, which will enable researchers to influence the activity of different kinds of neurons in any part of the brain without the need of major brain invasive surgery or complex genetic techniques.


Grant type
Capacity building grants
Area of Research
Central Nervous System
Competition
Azrieli Foundation - Brain Canada Early-Career Capacity Building grants
Province
Newfoundland and Labrador
Start Date
2019

2019 Dr. Hubert van Tol Travel Fellowship

My time in the Courtine laboratory provided an opportunity to obtain hands-on experience in the application of scRNA-seq to understand the pathobiology of SCI, through two different projects.


Grant type
Capacity building grants
Area of Research
Injury
Competition
Dr. Hubert van Tol Travel Fellowship
Province
British Columbia
Start Date
2019

Canadian Consortium on Neurodegeneration In Aging (CCNA) – Phase 2


Area of Research
Neurodegeneration
Start Date
2019